Daniel Kirby, Chief Commercial Officer of Iovance, stated, “The real world Amtagvi data with impressive response rates, ...

Spruce Biosciences, Inc. , a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders with significant unmet medical need, announced ...

Class Disrupted is an education podcast featuring author Michael Horn and Futre’s Diane Tavenner in conversation with ...

Hexagon Purus ASA ("Hexagon Purus" or the "Company"), a world leading manufacturer of zero-emission mobility and infrastructure solutions, has through one of its wholly ...

Hexagon Purus ASA ('Hexagon Purus' or the 'Company”), a world leading manufacturer of zero-emission mobility and ...

YouTube host Mark Tilbury agrees with Charlie Munger's advice for young Americans trying to build wealth.

AbbVie Inc. (NYSE:ABBV) Q4 2025 Earnings Call Transcript February 4, 2026 AbbVie Inc. beats earnings expectations. Reported ...

A webcast of the fireside chat will be available under the Events and Presentations section of the Company’s investor relations website at Cullinan Therapeutics, Inc. (Nasdaq: CGEM) is a ...

QuantumScape Corporation (QS) announced on Thursday the inauguration of its newly installed Eagle Line, a pivotal step for solid-state battery pilot production. This development marks a significant ...

David A. Ross said he remained “ashamed” for having been “taken in” by Jeffrey Epstein. Mr. Ross resigned his position at the School of Visual Arts in New York.

AI weapons detection leader, cash burn, high valuation, dilution, and more keep risks high. Click for this EVLV update.

Nearly 100 biotechs went public amid the industry’s IPO frenzy in 2021, driven by an influx of pandemic-driven investments. But many of those companies have little to show investors.